Pfizer agrees to buy Seagen for USD 43 bn
Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering class of targeted cancer drugs, The Wall Street Journal reported.
Source: parisguardian.com
Stay updated with breaking news from Eagen Which. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering class of targeted cancer drugs, The Wall Street Journal reported.